NPI registry status
Active
2026 NPPES data Cardiovascular Disease Physician NPI 1760722540
Verify on CMS → Tamara Ashvetiya
Cardiovascular Disease Physician in Baltimore, Maryland.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 24,810 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 333 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
80.2/100
▼ 3 pts below national avg 83.5 · Above neutral
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Tamara Ashvetiya reported a CMS MIPS final score of 80.2/100 - below the 83.5 national average - and filed 1,530 Medicare Part D claims in 2023.
- 80.2/100
- MIPS score · -3 vs avg
- 2K
- Part D claims, 2023
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1760722540 · Cardiovascular Disease Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-BELOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1760722540
- ENUM-MID 2013
- TAX-MID 25K Cardiovascular Disease
- MIPS-BELOW 80.2/100
- RX-MID 1,530
- BOOK-LIGHT 587 in Maryland
- PHOTO-FINISH Khalil Suaray · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Ashvetiya · this…
Ashvetiya · this provider
80.2 MIPS pts
- Hamed Bayat · hi…
Hamed Bayat
80.2 MIPS pts
- Mehdi Gheshlaghi…
Mehdi Gheshlaghi
80.2 MIPS pts
- Arsenio Rodrigue…
Arsenio Rodriguez
80.2 MIPS pts
- Khalil Suaray · …
Khalil Suaray
80.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Tamara Ashvetiya's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
80 ≥ 30th percentile 30% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Tamara Ashvetiya sits
This provider among cardiovascular disease physician peers
Across the 7,999 cardiovascular disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Tamara Ashvetiya writes more Part D claims than 33% of them and scores higher on MIPS quality than 29% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one cardiovascular disease physician peer from a representative sample of 60; the gold marker is Tamara Ashvetiya. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Tamara Ashvetiya practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Tamara Ashvetiya?
Near national averagePrimary specialty
Cardiovascular Disease Physician
Medicare Part D claims
1,530 50% vs specialty avg
MIPS final score
80.2/100 3.3 pts vs avg
Specialty distribution in Maryland
How Cardiovascular Disease Physician compares to other specialties among Maryland providers
Medicare quality performance, MIPS
Tamara Ashvetiya's 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 80.2/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1760722540 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Gender | Female |
| NPI Issued | 02/15/2013 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
80.1797
Final Score
Measured-score avg: 83.5
76.6904
Quality
53.4937
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Tamara Ashvetiya bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Medstar Heart Institute LLC
Baltimore, MD
Medstar Medical Group II LLC
Rosedale, MD
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
Tamara Ashvetiya - brand share 14.0%
Cardiovascular Disease Physician average
14% brand-name claims vs 86% generic, on 1,530 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,530
Total Claims
$291K
Total Drug Cost
333
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,186
- Total Day Supply
- 124,925
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $260K
- Generic Drug Cost
- $31K
Patient Demographics
- Average Patient Age
- 72.5 years
- Avg HCC Risk Score
- 1.60
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 46, 65-74: 148, 75-84: 99, 85+: 40
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Tamara Ashvetiya prescribes most
Top Medicare Part D drugs by claim count, 2023
- Metoprolol Succinate
Metoprolol Succinate
219 claims
- Amlodipine Besylate
Amlodipine Besylate
164 claims
- Atorvastatin Calcium
Atorvastatin Calcium
140 claims
- Eliquis
Eliquis
121 claims
- Furosemide
Furosemide
93 claims
- Losartan Potassium 78
Losartan Potassium
78 claims
- Lisinopril 63
Lisinopril
63 claims
- Carvedilol 56
Carvedilol
56 claims
| Drug | Claims |
|---|---|
| Metoprolol Succinate | 219 |
| Amlodipine Besylate | 164 |
| Atorvastatin Calcium | 140 |
| Eliquis Apixaban | 121 |
| Furosemide | 93 |
| Losartan Potassium | 78 |
| Lisinopril | 63 |
| Carvedilol | 56 |
| Ezetimibe | 51 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 51 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How Tamara Ashvetiya fits within the Cardiovascular Disease Physician landscape nationally.
24,810
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider
Tamara Ashvetiya's 1,530 claims are below the specialty average of 3,033.
Nationwide Cardiovascular Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ashvetiya, both outside Maryland so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (80.2 here).
Same NPPES enumeration year (2013)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Cardiovascular Disease Physician Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as Ashvetiya.
One of 587 Cardiovascular Disease Physician providers enrolled in Maryland, 5 are shown here.
Dr. Seyed Hossein Aalaei-Andabili
M.D
Baltimore, MD
Dr. Leith Abdulla
M.D.
Olney, MD
Dr. Rasaq Abu
M.D.
Berwyn Heights, MD
Dr. Mohammed Abuzahra
MD
Baltimore, MD
Dr. Stephen Achuff
M.D.
Baltimore, MD
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Tamara Ashvetiya's specialty? ▼
Tamara Ashvetiya specializes in Cardiovascular Disease Physician and practices in Baltimore, Maryland.
How much does Tamara Ashvetiya prescribe under Medicare Part D? ▼
In 2023, Tamara Ashvetiya wrote 1,530 Medicare Part D claims totaling $291K in drug costs for 333 beneficiaries.
What is Tamara Ashvetiya's Medicare quality score? ▼
Tamara Ashvetiya has a CMS MIPS Final Score of 80.2/100 (Quality: 76.7, Cost: 53.5). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Tamara Ashvetiya located? ▼
Tamara Ashvetiya is located at 9105 FRANKLIN SQUARE DR STE 209, Baltimore, MD, 21237. Phone: (410) 574-1330.
What is Tamara Ashvetiya's NPI number? ▼
Tamara Ashvetiya's National Provider Identifier (NPI) is 1760722540, issued on 02/15/2013.
Does Tamara Ashvetiya prescribe more brand-name or generic drugs? ▼
Tamara Ashvetiya's prescribing is 14% brand-name and 86% generic drugs by claim count, with $260K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US? ▼
There are 24,810 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does Tamara Ashvetiya prescribe most often? ▼
Based on 2023 Medicare Part D data, Tamara Ashvetiya's most frequently prescribed drugs include Metoprolol Succinate, Amlodipine Besylate, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Tamara Ashvetiya accept Medicare? ▼
Tamara Ashvetiya appears in CMS Medicare data with 1,530 Part D claims and 333 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Tamara Ashvetiya's credentials? ▼
Tamara Ashvetiya's NPI is 1760722540. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.